Related Experiment Video
Updated: Mar 7, 2026

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
7.5K
Does Body Mass Index Affect Mortality in Coronary Surgery?
1Division of Surgery, Department of Surgery and Cancer, Imperial College London, United Kingdom.
The Open Cardiovascular Medicine Journal
|February 21, 2017
Summary
Patients with extreme Body Mass Index (BMI) values undergoing coronary artery bypass grafting (CABG) face higher operative mortality. Underweight individuals had the highest mortality, while overweight patients had the lowest. Morbid obesity also increased risk.
Area of Science:
- Cardiology
- Surgical Outcomes
- Nutritional Science
Background:
- Body Mass Index (BMI) is a key indicator of nutritional status, classifying individuals into weight categories.
- Obesity (BMI > 30 kg/m²), defined as excessive fat accumulation, is recognized as a complicating factor in anesthesia and surgery.
- Obesity is a known risk factor for complications such as mediastinitis following coronary artery bypass grafting (CABG).
Purpose of the Study:
- To investigate the association between Body Mass Index (BMI) categories and operative mortality in patients undergoing coronary artery bypass grafting (CABG).
- To evaluate the impact of underweight, normal weight, overweight, and varying degrees of obesity on CABG outcomes.
Main Methods:
- A literature review was conducted on studies reporting CABG mortality stratified by BMI groups.
- BMI categories included: Underweight (≤18.49 kg/m²), normal weight (18.5-24.9 kg/m²), overweight (25.0-29.9 kg/m²), mild obesity (30.0-34.9 kg/m²), moderate obesity (35.0-39.9 kg/m²), and morbid obesity (≥40.0 kg/m²).
Main Results:
- Eighteen studies encompassing 1,027,711 patients were analyzed.
- The overall cumulative mortality for CABG was 2.7%.
- Underweight patients exhibited the highest mortality rate (6.6%), followed by morbidly obese patients (3.44%). Overweight patients had the lowest mortality (2.1%).
Conclusions:
- Extreme BMI values, both underweight and morbidly obese, are associated with increased crude mortality after CABG.
- Under-nutrition and morbid obesity warrant further investigation as significant risk factors in coronary surgery.
- Nutritional status is a critical factor influencing outcomes in patients undergoing CABG.
Related Concept Videos
Drug Dosing: Obese Patients
320
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
320
Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Coronary Artery Disease IV: Preventive Measures
789
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
789
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
335
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
335

